Literature DB >> 19355880

Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications.

Smaragda Oikonomidi1, Konstantinos Kostikas, Irene Tsilioni, Kalliopi Tanou, Konstantinos I Gourgoulianis, Theodoros S Kiropoulos.   

Abstract

Matrix metalloproteinases (MMPs) are zinc-endopeptidases responsible for degradation of the extracellular matrix (ECM) components including basement membrane collagen, interstitial collagen, fibronectin, and various proteoglycans, during normal remodeling and repair processes. The turnover and remodeling of ECM must be tightly regulated since excessive or inappropriate expression of MMPs may contribute to the pathogenesis of tissue destructive processes associated with lung inflammation and disease. Despite the fact that our knowledge in the field of MMP biology is rapidly expanding, the role of MMPs in the pathogenesis of lung diseases is still not clear. The aim of the present review is to present the basic principles of MMP biology and, subsequently, to focus on the clinical and experimental evidence related to MMP activity in various lung disorders, including lung cancer, pleural effusions, chronic obstructive pulmonary disease, asthma, acute respiratory distress syndrome and interstitial lung diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19355880     DOI: 10.2174/092986709787846587

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  22 in total

1.  Classical and alternative macrophage activation in the lung following ozone-induced oxidative stress.

Authors:  Vasanthi R Sunil; Kinal Patel-Vayas; Jianliang Shen; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2012-06-19       Impact factor: 4.219

Review 2.  Paracrine functions of fibrocytes to promote lung fibrosis.

Authors:  Kathryn R Kleaveland; Bethany B Moore; Kevin K Kim
Journal:  Expert Rev Respir Med       Date:  2014-01-22       Impact factor: 3.772

Review 3.  Peripheral blood biomarkers in idiopathic pulmonary fibrosis.

Authors:  Rekha Vij; Imre Noth
Journal:  Transl Res       Date:  2012-02-02       Impact factor: 7.012

4.  Effect of tumor suppressor PTEN gene on apoptosis and cell cycle of human airway smooth muscle cells.

Authors:  Liang Luo; Yuan Qi Gong; Xiefei Qi; Wenyan Lai; Haibing Lan; Yaling Luo
Journal:  Mol Cell Biochem       Date:  2012-12-29       Impact factor: 3.396

5.  The PPARγ agonist, rosiglitazone, attenuates airway inflammation and remodeling via heme oxygenase-1 in murine model of asthma.

Authors:  Jing Xu; Yan-ting Zhu; Gui-zuo Wang; Dong Han; Yuan-yuan Wu; De-xin Zhang; Yun Liu; Yong-hong Zhang; Xin-ming Xie; Shao-jun Li; Jia-mei Lu; Lu Liu; Wei Feng; Xiu-zhen Sun; Man-xiang Li
Journal:  Acta Pharmacol Sin       Date:  2015-01-26       Impact factor: 6.150

6.  Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.

Authors:  R Kremer; L A Best; D Savulescu; M Gavish; R M Nagler
Journal:  Br J Cancer       Date:  2010-03-09       Impact factor: 7.640

7.  Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis.

Authors:  Diana J Leeming; Jannie M Sand; Mette J Nielsen; Federica Genovese; Fernando J Martinez; Cory M Hogaboam; Meilan K Han; Lloyd B Klickstein; Morten A Karsdal
Journal:  Biomark Insights       Date:  2012-09-13

8.  Therapeutic effects of C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice.

Authors:  Yan-Yang Wang; Cui-Ying Zhang; Ya-Qiong Ma; Zhi-Xu He; Hong Zhe; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-06-22       Impact factor: 4.162

9.  Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis.

Authors:  Eugenio Hardy; Carlos Fernandez-Patron
Journal:  Biomolecules       Date:  2021-03-06

10.  Serum biomarker analysis of collagen disease patients with acute-onset diffuse interstitial lung disease.

Authors:  Shomi Oka; Hiroshi Furukawa; Kota Shimada; Hiromi Hayakawa; Naoshi Fukui; Naoyuki Tsuchiya; Shigeto Tohma
Journal:  BMC Immunol       Date:  2013-02-14       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.